Issues in antithrombin therapy for UA/NSTEMI
Issues in antiplatelet therapy for UA/NSTEMI
Issues in cardiac intervention for UA/NSTEMI
STEMI and NSTEMI are two distinct pathophysiological entities
Issues in early risk stratification for UA/NSTEMI
Issues in discharge therapy after hospitalization for UA/NSTEMI
STEMI and NSTEMI are two distinct pathophysiological entities: reply
STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry)†
STEMI and NSTEMI: the dangerous brothersThe opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.
Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS–NSTEMI randomized trial
An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS
58 Admission Killip class or previous NYHA class: what is more important for long-term outcomes in unselected STEMI and NSTEMI/UA patients treated according to contemporary guidelines?
Show all results sharing this subject:
Non-S–T elevation myocardial infarction.
Concise Medical Dictionary »
Medicine and Health.
See all related items in Oxford Index »
Search for the text `NSTEMI' anywhere in Oxford Index »
Users without a subscription are not able to see the full content. Please,
or login to access all content.
Forgot your password?